8-K Announcements
6Material company update
Apr 22, 2026·SEC
Material company update
Mar 19, 2026·SEC
Material company update
Jan 13, 2026·SEC
Aclarion, Inc.(ACON)Earnings, Financials & Key Ratios
ACON•NASDAQ
Price updated Jun 19, 2026
AboutAclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.Show more
- Revenue$76K+65.6%
- EBITDA-$7M-28.3%
- Net Income-$7M-3.4%
- EPS (Diluted)-13.61+99.8%
- Gross Margin-291.27%-58.5%
- EBITDA Margin-9012.26%+22.5%
- Operating Margin-9312.55%+22.8%
- Net Margin-9551.87%+37.5%
- ROE-104.8%+98.2%
ACON Key Insights
Aclarion, Inc. (ACON) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.1x book value
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ACON posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ACON Price & Volume
Aclarion, Inc. (ACON) stock price & volume — 10-year historical chart
Loading chart...
ACON Growth Metrics
Aclarion, Inc. (ACON) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years9.25%
3 Years7.8%
TTM42.63%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-21.39%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM99.78%
Return on Capital
10 Years-1389.53%
5 Years-1389.53%
3 Years-1769.42%
Last Year-102.17%
ACON Recent Earnings
Aclarion, Inc. (ACON) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 2/12 qtrs (18%)
Q2 2026Latest
May 21, 2026Metric
Actual
Est
EPS
$1.34+13.5%
$1.55
Rev
$21,140-15.4%
$25,000
Q2 2026
May 13, 2026Metric
Actual
Est
EPS
$1.34+13.5%
$1.55
Rev
$21,140-15.4%
$25,000
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$3.60+0.0%
$3.60
Rev
$20,000+0.0%
$20,000
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$2.93-11.0%
$2.64
Rev
$18,942-0.3%
$19,000
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 21, 2026 | $1.34vs $1.55+13.5% | $21,140vs $25,000-15.4% |
| Q2 2026 | May 13, 2026 | $1.34vs $1.55+13.5% | $21,140vs $25,000-15.4% |
| Q1 2026 | Feb 25, 2026 | $3.60vs $3.60+0.0% | $20,000vs $20,000+0.0% |
| Q4 2025 | Nov 12, 2025 | $2.93vs $2.64-11.0% | $18,942vs $19,000-0.3% |
Based on last 12 quarters of dataView full earnings history →
ACON Peer Comparison
Aclarion, Inc. (ACON) competitors in Life Sciences and Precision Medicine Software — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 XTNT | 61.8M | 0.44 | 14.69 | 14.21% | 1.5% | 3.68% | 0.56 | |
 GKOS | 7.65B | 130.68 | -39.84 | 32.33% | -34.34% | -26.46% | 0.21 | |
 MDXG | 545.24M | 3.67 | 11.47 | 19.99% | 7.88% | 12.86% | 0.09 | |
 ATEC | 1.33B | 8.81 | -9.18 | 24.95% | -21.07% | -443.09% | 17.21 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 OFIX | 381.98M | 9.45 | -4.14 | 2.85% | -7.27% | -13.44% | 0.51 | |
 ISRG | 144.48B | 406.78 | 51.69 | 20.51% | 28.15% | 16.89% | 0.02 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 |
Compare ACON vs Peers
Aclarion, Inc. (ACON) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ACON Income Statement
Aclarion, Inc. (ACON) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 26.9K | 48.65K | 60.29K | 60.44K | 75.4K | 45.72K | 75.73K | 77.88K |
Revenue Growth % | - | 80.88% | 23.93% | 0.25% | 24.75% | -39.36% | 65.62% | 42.63% |
Cost of Goods Sold | 63.18K | 66.25K | 69.17K | 65.3K | 75.73K | 129.77K | 296.31K | 123.72K |
COGS % of Revenue | 234.9% | 136.16% | 114.73% | 108.03% | 100.43% | 283.81% | 391.27% | - |
Gross Profit | -36.28K▲ 0% | -17.59K▲ 51.5% | -8.88K▲ 49.5% | -4.85K▲ 45.4% | -324▲ 93.3% | -84.04K▼ 25839.2% | -220.58K▼ 162.5% | -45.84K▲ 0% |
Gross Margin % | -134.9% | -36.16% | -14.73% | -8.03% | -0.43% | -183.81% | -291.27% | -58.86% |
Gross Profit Growth % | - | 51.51% | 49.51% | 45.36% | 93.33% | -25839.2% | -162.46% | - |
Operating Expenses | 3.98M | 4.46M | 2.94M | 5.56M | 4.88M | 5.43M | 6.83M | 8.5M |
OpEx % of Revenue | 14786.11% | 9166.87% | 4883.16% | 9193.16% | 6466.05% | 11873.42% | 9021.28% | - |
Selling, General & Admin | 2.24M | 1.41M | 2.16M | 4.49M | 4M | 4.59M | 6.03T | 7.41M |
SG&A % of Revenue | 8329.58% | 2893.48% | 3576.44% | 7426.25% | 5307.84% | 10028.32% | 99999900% | - |
Research & Development | 1.74M | 1.05M | 787.85K | 1.07M | 873.34K | 888.77K | 1.03T | 1.15M |
R&D % of Revenue | 6456.53% | 2162.56% | 1306.72% | 1766.91% | 1158.21% | 1943.76% | 99999900% | - |
Other Operating Expenses | 0 | 2M | 0 | 0 | 0 | -45.11K | -7.06T | -60.91K |
Operating Income | -4.01M▲ 0% | -4.48M▼ 11.6% | -2.95M▲ 34.0% | -5.56M▼ 88.3% | -4.88M▲ 12.3% | -5.51M▼ 13.1% | -7.05M▼ 27.9% | -8.55M▲ 0% |
Operating Margin % | -14921.01% | -9203.03% | -4897.89% | -9201.19% | -6466.48% | -12057.23% | -9312.55% | -10975.1% |
Operating Income Growth % | - | -11.57% | 34.05% | -88.33% | 12.33% | -13.07% | -27.92% | - |
EBITDA | -3.84M | -4.28M | -2.77M | -5.42M | -4.71M | -5.32M | -6.82M | -8.31M |
EBITDA Margin % | -14258.45% | -8799.59% | -4588.75% | -8963.58% | -6250.74% | -11634.83% | -9012.26% | -10675.73% |
EBITDA Growth % | - | -11.63% | 35.38% | -95.83% | 13.01% | -12.87% | -28.29% | -50.44% |
D&A (Non-Cash Add-back) | 178.21K | 196.28K | 186.39K | 143.62K | 162.67K | 193.14K | 227.41K | 233.15K |
EBIT | -4.01M | -4.48M | -4.47M | -5.56M | -4.3M | -6.46M | -7.05M | -8.18M |
Net Interest Income | -5K | -156.04K | -476.48K | -1.51M | -608.12K | -535.15K | 411.06K | 133.03K |
Interest Income | 0 | 15 | 0 | 2.51K | 172 | 318 | 411.06K | 133.03K |
Interest Expense | 5K | 156.06K | 476.48K | 1.51M | 608.29K | 535.47K | 0 | 0 |
Other Income/Expense | -5.96K | -157.79K | -2M | -1.51M | -35.39K | -1.48M | -181.24K | 497.64K |
Pretax Income | -4.02M▲ 0% | -4.64M▼ 15.3% | -4.95M▼ 6.8% | -7.07M▼ 42.8% | -4.91M▲ 30.5% | -6.99M▼ 42.4% | -7.23M▼ 3.4% | -8.05M▲ 0% |
Pretax Margin % | -14943.15% | -9527.35% | -8210.53% | -11694.45% | -6513.41% | -15293.78% | -9551.87% | -10336.12% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -4.02M▲ 0% | -4.64M▼ 15.3% | -4.95M▼ 6.8% | -7.07M▼ 42.8% | -4.91M▲ 30.5% | -6.99M▼ 42.4% | -7.23M▼ 3.4% | -8.05M▲ 0% |
Net Margin % | -14943.15% | -9527.35% | -8210.53% | -11694.45% | -6513.41% | -15293.78% | -9551.87% | -10336.12% |
Net Income Growth % | - | -15.33% | -6.8% | -42.79% | 30.52% | -42.38% | -3.44% | -21.39% |
Net Income (Continuing) | -4.02M | -4.64M | -4.95M | -7.07M | -4.91M | -6.99M | -7.23M | -8.05M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -97680.00▲ 0% | -110583.00▼ 13.2% | -120035.00▼ 8.5% | -177396.00▼ 47.8% | -79782.00▲ 55.0% | -7480.22▲ 90.6% | -13.61▲ 99.8% | -3.78▲ 0% |
EPS Growth % | - | -13.21% | -8.55% | -47.79% | 55.03% | 90.62% | 99.82% | 99.78% |
EPS (Basic) | -97680.00 | -110583.00 | -120035.00 | -177396.00 | -79782.00 | -7480.22 | -13.61 | - |
Diluted Shares Outstanding | 50 | 50 | 50 | 42 | 62 | 943 | 532.04K | 2.13M |
Basic Shares Outstanding | 50 | 50 | 50 | 42 | 62 | 943 | 532.04K | 2.13M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
ACON Balance Sheet
Aclarion, Inc. (ACON) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 218.51K | 97.13K | 732.2K | 1.7M | 1.29M | 824.28K | 12.4M | 19.38M |
Cash & Short-Term Investments | 128.16K | 14.98K | 432.53K | 1.47M | 1.02M | 453.66K | 12.02M | 19M |
Cash Only | 128.16K | 14.98K | 432.53K | 1.47M | 1.02M | 453.66K | 12.02M | 19M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 14.7K | 22.5K | 6.28K | 18.65K | 13.42K | 18.33K | 29.68K | 40.58K |
Days Sales Outstanding | 199.42 | 168.82 | 38.02 | 112.64 | 64.98 | 146.29 | 143.05 | 144.35 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - |
Other Current Assets | 0 | 0 | 20K | 59.56K | 152.22K | 133.9K | 25K | 330.99K |
Total Non-Current Assets | 1.21M | 1.19M | 1.16M | 1.21M | 1.17M | 1.3M | 1.28M | 1.26M |
Property, Plant & Equipment | 48.51K | 25.62K | 12.64K | 3.35K | 1.78K | 5.5K | 24.17K | 22.87K |
Fixed Asset Turnover | 0.55x | 1.90x | 4.77x | 18.06x | 42.31x | 8.31x | 3.13x | 4.67x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 1.16M | 1.17M | 1.14M | 1.21M | 1.17M | 1.29M | 1.25M | 1.24M |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Assets | 1.43M▲ 0% | 1.29M▼ 9.7% | 1.89M▲ 46.3% | 2.91M▲ 54.3% | 2.46M▼ 15.6% | 2.12M▼ 13.7% | 13.67M▲ 543.9% | 20.64M▲ 0% |
Asset Turnover | 0.02x | 0.04x | 0.03x | 0.02x | 0.03x | 0.02x | 0.01x | 0.01x |
Asset Growth % | - | -9.69% | 46.27% | 54.26% | -15.61% | -13.67% | 543.87% | 1260.85% |
Total Current Liabilities | 3.13M | 8.38M | 7.62M | 688.67K | 3.19M | 1.15M | 837.29K | 986.21K |
Accounts Payable | 501.03K | 859.53K | 1.06M | 457.56K | 760.53K | 531.6K | 324.47K | 587.29K |
Days Payables Outstanding | 2.89K | 4.74K | 5.59K | 2.56K | 3.67K | 1.5K | 399.69 | 1.08K |
Short-Term Debt | 515.55K | 2.38M | 2M | 0 | 1.13M | 0 | 0 | 0 |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2.02M | 2M | 0 | 165.95K | 768.87K | 543.12K | 459.67K | 398.92K |
Current Ratio | 0.07x | 0.01x | 0.10x | 2.47x | 0.40x | 0.71x | 14.81x | 19.65x |
Quick Ratio | 0.07x | 0.01x | 0.10x | 2.47x | 0.40x | 0.71x | 14.81x | 19.65x |
Cash Conversion Cycle | - | - | - | - | - | - | - | -938.09 |
Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3.13M | 8.38M | 7.62M | 688.67K | 3.19M | 1.15M | 837.29K | 986.21K |
Total Debt | 515.55K | 2.38M | 2M | 0 | 1.13M | 0 | 0 | 0 |
Net Debt | 387.39K | 2.36M | 1.57M | -1.47M | 104.66K | -453.66K | -12.02M | -19M |
Debt / Equity | - | - | - | - | - | - | - | 0.00x |
Debt / EBITDA | - | - | - | - | - | - | - | -0.00x |
Net Debt / EBITDA | - | - | - | - | - | - | - | 2.29x |
Interest Coverage | -803.66x | -28.70x | -9.39x | -3.69x | -7.07x | -12.06x | - | - |
Total Equity | -1.7M▲ 0% | -7.08M▼ 316.2% | -5.73M▲ 19.1% | 2.23M▲ 138.9% | -728K▼ 132.7% | 970.06K▲ 233.3% | 12.84M▲ 1223.1% | 19.65M▲ 0% |
Equity Growth % | - | -316.21% | 19.12% | 138.85% | -132.7% | 233.25% | 1223.13% | 2409.85% |
Book Value per Share | -34300.81 | -142762.87 | -115468.66 | 52761.77 | -11825.83 | 1028.87 | 24.12 | 9.23 |
Total Shareholders' Equity | -1.7M | -7.08M | -5.73M | 2.23M | -728K | 970.06K | 12.84M | 19.65M |
Common Stock | 68 | 68 | 9 | 5 | 8 | 0 | 9 | 25 |
Retained Earnings | -20.44M | -25.93M | -31.89M | -39.37M | -44.28M | -51.26M | -58.5M | -61.35M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ACON Cash Flow Statement
Aclarion, Inc. (ACON) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | -4.17M | -1.79M | -2.35M | -4.95M | -3.65M | -5.27M | -7.16M | -7.3M |
Operating CF Margin % | -15508.17% | -3687.01% | -3897.61% | -8187.93% | -4836.54% | -11529.19% | -9460.19% | - |
Operating CF Growth % | - | 57% | -31% | -110.61% | 26.31% | -44.55% | -35.9% | -155.91% |
Net Income | -4.02M | -4.64M | -4.95M | -7.07M | -4.91M | -6.99M | -7.23M | -8.05M |
Depreciation & Amortization | 178.21K | 196.28K | 189.37K | 143.62K | 162.67K | 193.14K | 227.41K | 233.15K |
Stock-Based Compensation | 28.04K | 26.13K | 177.49K | 1.29M | 456K | 287.45K | 0 | 49.47K |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 0 | 2.08M | 1.56M | 1.3M | 22.88K | 1.8M | 199.92K | 4.59K |
Working Capital Changes | -358.23K | 539.9K | 676.29K | -616.1K | 622.87K | -564.24K | -357.9K | 467.29K |
Change in Receivables | -14.7K | -7.81K | 16.22K | -12.29K | -1.49K | 7.27K | -11.35K | -21.41K |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -249.96K | 342.23K | 199.6K | -603.1K | 220.63K | -156.4K | -198.64K | 58.89K |
Cash from Investing | -267.21K | -179.03K | -152K | -207.87K | -119.52K | -321.94K | -203.9K | -174.96K |
Capital Expenditures | -22.36K | -4.74K | -152K | -208.87K | -119.52K | -321.94K | -203.9K | -174.96K |
CapEx % of Revenue | 83.12% | 9.74% | 252.11% | 345.56% | 158.51% | 704.09% | 269.25% | 224.65% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - |
Other Investing | -244.86K | -174.28K | 0 | 1K | 0 | 0 | 0 | 1 |
Cash from Financing | 2.95M | 1.86M | 2.94M | 6.19M | 3.31M | 5.03M | 18.95M | 11.74M |
Debt Issued (Net) | 515.55K | 1.86M | 2.94M | -2M | 2.25M | -300.97K | 0 | 0 |
Equity Issued (Net) | 2.43M | 0 | 0 | 8.55M | 1.46M | 6.57M | 18.95M | 11.9M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -1.21M | 0 |
Other Financing | 0 | 0 | 0 | -365.06K | -398.22K | -1.25M | 0 | -164.65K |
Net Change in Cash | -1.49M▲ 0% | -113.18K▲ 92.4% | 437.55K▲ 486.6% | 1.03M▲ 135.5% | -451.74K▼ 143.8% | -567.41K▼ 25.6% | 11.58M▲ 2140.4% | 4.27M▲ 0% |
Free Cash Flow | -4.44M▲ 0% | -1.97M▲ 55.6% | -2.35M▼ 19.1% | -5.16M▼ 119.5% | -3.77M▲ 27.0% | -5.59M▼ 48.5% | -7.19M▼ 28.5% | -7.34M▲ 0% |
FCF Margin % | -16501.65% | -4054.98% | -3897.61% | -8533.49% | -4995.05% | -12233.28% | -9488.62% | -9430.56% |
FCF Growth % | - | 55.55% | -19.12% | -119.49% | 26.98% | -48.51% | -28.46% | -57.84% |
FCF per Share | -89452.45 | -39760.38 | -47360.88 | -122259.39 | -61183.95 | -5932.66 | -13.51 | -3.45 |
FCF Conversion (FCF/Net Income) | 1.04x | 0.39x | 0.47x | 0.70x | 0.74x | 0.75x | 0.99x | 0.91x |
Interest Paid | 0 | 0 | 0 | 0 | 10.71K | 13.07K | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ACON Key Ratios
Aclarion, Inc. (ACON) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | - | -317.55% | -655.74% | -5777.8% | -104.8% | -54.41% |
Return on Invested Capital (ROIC) | - | - | - | -5634.28% | - | -791.97% | -642.26% |
Gross Margin | -36.16% | -14.73% | -8.03% | -0.43% | -183.81% | -291.27% | -58.86% |
Net Margin | -9527.35% | -8210.53% | -11694.45% | -6513.41% | -15293.78% | -9551.87% | -10336.12% |
Debt / Equity | - | - | - | - | - | - | 0.00x |
Interest Coverage | -28.70x | -9.39x | -3.69x | -7.07x | -12.06x | - | - |
FCF Conversion | 0.39x | 0.47x | 0.70x | 0.74x | 0.75x | 0.99x | 0.91x |
Revenue Growth | 80.88% | 23.93% | 0.25% | 24.75% | -39.36% | 65.62% | 42.63% |
Related:ACON Dividend History·ACON Revenue History·ACON Price History·ACON P/E History·ACON Financial Ratios·ACON Institutional Holders
ACON SEC Filings & Documents
Aclarion, Inc. (ACON) SEC filings — annual & quarterly reports (10-K, 10-Q)
ACON Frequently Asked Questions
Aclarion, Inc. (ACON) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Aclarion, Inc. (ACON) reported $0.1M in revenue for fiscal year 2025. This represents a 190% increase from $0.0M in 2019.
Aclarion, Inc. (ACON) grew revenue by 65.6% over the past year. This is strong growth.
Aclarion, Inc. (ACON) reported a net loss of $8.0M for fiscal year 2025.
Dividend & Returns
Aclarion, Inc. (ACON) has a return on equity (ROE) of -104.8%. Negative ROE indicates the company is unprofitable.
Aclarion, Inc. (ACON) had negative free cash flow of $7.3M in fiscal year 2025, likely due to heavy capital investments.